Combined onabotulinumtoxinA/atogepant treatment blocks activation/sensitization of high-threshold and wide-dynamic range neurons.

Cephalalgia : an International Journal of Headache
Agustin Melo-CarrilloRami Burstein

Abstract

OnabotulinumtoxinA and agents that block calcitonin gene‒receptor peptide action have both been found to have anti-migraine effects, but they inhibit different populations of meningeal nociceptors. We therefore tested the effects of combined treatment with onabotulinumtoxinA and the calcitonin gene‒receptor peptide antagonist atogepant on activation/sensitization of trigeminovascular neurons by cortical spreading depression. Single-unit recordings were obtained of high-threshold and wide-dynamic-range neurons in the spinal trigeminal nucleus, and cortical spreading depression was then induced in anesthetized rats that had received scalp injections of onabotulinumtoxinA 7 days earlier and intravenous atogepant infusion 1 h earlier. The control group received scalp saline injections and intravenous vehicle infusion. OnabotulinumtoxinA/atogepant pretreatment prevented cortical spreading depression-induced activation and sensitization in both populations (control: Activation in 80% of high-threshold and 70% of wide-dynamic-range neurons, sensitization in 80% of high-threshold and 60% of wide-dynamic-range neurons; treatment: activation in 10% of high-threshold and 0% of wide-dynamic-range neurons, sensitization in 0% of high-thresh...Continue Reading

References

May 15, 1998·Neuron·W D Snider, S B McMahon
Feb 23, 1999·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·A May, P J Goadsby
Nov 24, 1999·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·M J MorenoE Hamel
Mar 26, 2003·Annual Review of Neuroscience·A D Bud Craig
Apr 7, 2004·The Journal of Biological Chemistry·Cruz Morenilla-PalaoAntonio Ferrer-Montiel
Feb 24, 2006·Journal of Neurophysiology·Andrew M Strassman, Dan Levy
Mar 18, 2006·Science·Min DongEdwin R Chapman
Nov 23, 2006·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·J O Dolly, K R Aoki
Oct 20, 2009·Cell·Allan I BasbaumDavid Julius
Jul 22, 2010·Cephalalgia : an International Journal of Headache·S K AuroraUNKNOWN PREEMPT 1 Chronic Migraine Study Group
Jul 22, 2010·Cephalalgia : an International Journal of Headache·H C DienerUNKNOWN PREEMPT 2 Chronic Migraine Study Group
Nov 12, 2010·Nature Reviews. Neuroscience·Andrew J Todd
Mar 19, 2011·Annals of Neurology·Xichun ZhangRami Burstein
Nov 2, 2012·Neurology·Jakob M HansenAndrew Charles
Aug 21, 2013·The Journal of Pain : Official Journal of the American Pain Society·Sajedeh EftekhariLars Edvinsson
Apr 4, 2014·Cephalalgia : an International Journal of Headache·Rami BursteinMitchell F Brin
Jul 1, 2014·Nature Reviews. Microbiology·Ornella RossettoCesare Montecucco
Sep 27, 2014·Membranes·Clotilde Ferrandiz-HuertasAntonio Ferrer-Montiel
May 1, 2015·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Rami BursteinDavid Borsook
Jun 24, 2017·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Agustin Melo-CarrilloRami Burstein
Oct 4, 2017·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Agustin Melo-CarrilloRami Burstein
Oct 24, 2017·British Journal of Pharmacology·Debbie L HayChristopher S Walker
Nov 25, 2017·The New England Journal of Medicine·Stephen D SilbersteinErnesto Aycardi
Jun 5, 2019·Lancet Neurology·Messoud AshinaMichael A Moskowitz
Jul 11, 2019·The New England Journal of Medicine·Richard B LiptonPeter J Goadsby

❮ Previous
Next ❯

Citations

Jun 16, 2021·Expert Opinion on Drug Safety·Amanda Tinsley, John Farr Rothrock
Oct 13, 2021·Postgraduate Medicine·Ryan Patel, Anthony H Dickenson
Nov 24, 2021·Drugs·Emma D Deeks

❮ Previous
Next ❯

Software Mentioned

Spike

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.